Get ready for the DTC onslaught for this dog of a drug:
The device has been faring very poorly. Sales last year were just a few million dollars and Pfizer sales reps have carped about being unable to meet quotas. Recent market share data shows Exubera losing still more ground.Of course, Pfizer will likely annoy some doctors and politicians, who don’t fancy ads that encourage patients to demand expensive treatments. Exubera costs about $600 more than injectable insulin. But who cares if insurers pay for that bong-like experience?
(via PharmaGossip)
Related posts:
- Exubera: "Another blow for the bong"
- Pfizer blows Exubera away
- Why Exubera failed
- Exubera: A total failure
- Bloodbath at Pfizer
- ADA on Exubera
- Exubera TV ads
KevinMD.com on Facebook
{ 2 comments }
I quite talking to drug reps several years ago. They don’t “detail” products anymore, they sell them, with all the manipulation and distortion that go along with that.
If enough doctors locked them out and told them that they were tired of the DTC ads making their lives harder pushing people to want things they don’t need, they might back off.
Providers should quit being hypocrites! Don’t we welcome those reps and the drug companies they represent when we need sponsorship for CME, software/hardware, and occassional lunch treat for the office staff [that wont have to come out of our pockets]? The reps and DTC is not the root of the problem; its the economy and American/human hunger for the expensive best – even if its not affordable [it will implode somehow]. The REAL source of our headaches are not the reps…its the PBMs who work for their money by requiring prior authorizations and such; in other words, PBMs and Pharm “DOCTORs” – outstanding doctor wannabe’s – who were smart enough not to go to medical school to face whining, unprofessional, downright uneducated and uneducable patients.PBMs practice without having to pay for professional liability, and make more than net of a lot of real doctors…they got it great dont they?
Comments on this entry are closed.